StockData
KIDSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

ORTHOPEDIATRICS CORP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$22.03+0.08 (+0.36%)

Close on Oct 19, 2026

Market cap
$529.79M
P/E (TTM)
–
Dividend yield
–

Earnings

Next report expected Oct 27, 2026, during market hours (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Aug 4, 2026During market hours$70.50M$-0.30–
Q1 FY2026
Ended Mar 31, 2026
Apr 30, 2026During market hours$59.40M$-0.45$-0.42
Q4 FY2025
Ended Dec 31, 2025
Feb 26, 2026During market hours$61.60M$-0.43$-0.26
Q3 FY2025
Ended Sep 30, 2025
Oct 28, 2025During market hours$61.20M$-0.50$-0.24
Q2 FY2025
Ended Jun 30, 2025
Aug 5, 2025During market hours$61.10M$-0.30$-0.11
Q1 FY2025
Ended Mar 31, 2025
May 7, 2025During market hours$52.40M$-0.46$-0.39
Q4 FY2024
Ended Dec 31, 2024
Mar 4, 2025During market hours$52.70M$-0.69$-0.29
Q3 FY2024
Ended Sep 30, 2024
Nov 6, 2024During market hours$54.60M$-0.34$-0.18
Q2 FY2024
Ended Jun 30, 2024
Aug 5, 2024During market hours$52.80M$-0.26$-0.23
Q1 FY2024
Ended Mar 31, 2024
May 6, 2024During market hours–––
Q4 FY2023
Ended Dec 31, 2023
Mar 6, 2024During market hours–––

Company guidance

Outlook given with results on Aug 4, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
annual set deploymentannual$10.00MNew
adjusted EBITDAnon-GAAP2026$25.00MMaintained
growth over 2025 revenuefull year of 202612% to 14% growthRaised
revenue guidancefull year of 2026$265.00M to $269.00MRaised

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Orthopediatrics filed with the SEC